Solar UV exposure and mortality from skin tumors

Advances in Experimental Medicine and Biology

Volumn 624, Issue , 2008, Pages 117-124

  Berwick, Marianne ^a   Lachiewicz, Anne ^b   Pestak, Claire ^b   Thomas, Nancy ^b  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

ALGORITHM; CANCER MORTALITY; CANCER SURVIVAL; GEOGRAPHY; HUMAN; LATITUDE; MELANOMA; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; SOLAR RADIATION; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; EPIDEMIOLOGY; MORTALITY; RADIATION RESPONSE; RISK FACTOR; SKIN TUMOR; ULTRAVIOLET RADIATION;

CAUSALITY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; RISK FACTORS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 42949083752     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-77574-6_10     Document Type: Review

References (30)

1. Krickcr A, Armstrong BK, Goumas C ct al. Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control 2007; 18(3):295-304.
2. Freedman DM, Dosemeci M, McGlynn K. Sunlight and mortality from breast, ovarian, colon, prostate and nonmelanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med 2002; 59(4):257-62.
3. Grant WB. An ecologic study of cancer mortality in Spain with respect to indices of solar UVB irradiance and smoking. International Journal of Epidemiology 120(5):1123-1128.
4. Pcnnello, Gene. Devesa Susan, Gail et al. Association of Surface Ultraviolet B Radiation Levels with Melanoma and Nonmelanoma skin Cancer in United States Blacks. Cancer Epidemiology, Biomarkcrs and Prevention 2000; 9:291-197.
5. Lemish WM, Heenan PJ, Holman CD et aL Survival from pre-invasive and invasive malignant melanoma in Western Australia. Cancer 1983; 52:580-5.
6. Armstrong BK. Ch 6. Epidemiology of melanoma and current trends. In Textbook of Melanoma, London; Martin Dunitz 2006; 65-80.
7. Lachiewicz AM, Berwick M, Wiggins CL et al. N Survival Differences between Scalp/Neck Melanoma and Melanoma of Other Sites in the Surveillance, Epidemiology and End Results (SEER) Program (In preparation).
8. Jemal A, Sevesa S, Fears T et al. Cancer surveillance series: changing patterns of cutaneous maUgnant melanoma mortality rates among whites in "the United States. Journal of the National Cancer Institute 2000;92:811-818.
9. Bulliard JL. Site-Specific risk of cutaneous malignant melanoma and pattern of sun exposure in New Zealand. Int J Cancer 2000; 85:627-632.
10. Boscoe FP, Schymura MJ. Solar ultraviolet-B exposure and cancer incidence and mortaUty in the United States, 1993-2002. BMC Cancer 2006; 6:264.
11. Elwood JM, Lee JA, Walter SD et al. Relationship of melanoma and other skin cancer mortality to latitude and ultraviolet radiation in the United States and Canada. Int J Epidemiol 1974; 3:325-32.
12. Garland CF, Garland FC, Gorham ED. Epidemiologic evidence for different roles of Ultraviolet A and B Radiation in melanoma mortality rates. Annals of Epidemiology 2003; 13:395-404.
13. Boniol M, Armstrong BK, Dore JE Variation in incidence and fatality of melanoma by season of diagnosis in New South Wales, Australia. Cancer Epidemiol Biomarkers Prev 2006; 15:524-6.
14. Morales Suarez-Varela M, Llopis-Gonzalez A, Lacasana-Navarro M et al. Trends in malignant skin melanoma and other skin cancers in Spain, 1975-1983 and their relation to solar radiation intensity. Journal Environmental Pathology, Toxicology, Oncology 1990; 10:245-253.
15. Gass R, Bopp M. Mortality from malignant melanoma: epidemiological trends in Switzerland. Schweiz Rundsch Med Prax 2005; 94:1295-300.
16. Nelemans PJ, Rampen FH, Ruiter DJ et al. An addition to the controversy on sunlight exposure and melanoma risk: a meta-analytical approach. J Clin Epidemiol 1995; 48:1331-42.
17. Elwood JM, Jopson J. Melanoma and sim exposure: an overview of published studies. Int J Cancer 1997; 73:198-203.
18. Gandini S, Sera F, Cattaruzza MS et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005; 41(l):45-60.
19. Lee JA. Declining effect of latitude on melanoma mortality rates in the United States. A preliminary study Am J Epidemiol 1997; 146:413-7.
20. Lee JA, Scotto J. Melanoma: linked temporal and latitude changes in the United States. Cancer Causes Control 1993; 4:413-8.
21. Fears et al.
22. Page W, Whiteman D, Murphy M. A comparison of melanoma mortality among WWII veterans of the Pacific and European theatres. Ann Epidemiol 2000; 10:192-195.
23. Larsen TE, Crude TH. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 6. The relation of dermal solar elastosis to sex, age and survival of the patient and to localization, histological type and level of invasion of the tumour. Acta Pathol Microbiol Scand 1979; 87A:361-366.
24. Berwick M, Armstrong BK, Ben-Porat L et al. Sun exposure and mortality from melanoma. Journal of the National Cancer Institute 2005; 97:195-198.
25. Heenan PJ, English DR, Holman CD et al. Survival among patients with clinical stage I cutaneous maUgnant melanoma diagnosed in Western Australia in 1975/76 and 1980/81. Cancer 1991; 65:2079-87.
26. Zanetti R, Rosso S and the Helios Study. Sun exposure habits in an Italian population and survival from melanoma (In preparation).
27. Gilchrest BA, Eller MS, Geller AC et al. The pathogenesis of melanoma induced by ultraviolet radiation. New England J Med 1999; 340(17)1341-1348.
28. Vandwalle B, Wattcz N, Lefebvrc J. Effects of vitamin D3 derivatives on growth, differentiation and apoptosis in tumoral colonic HT 29 cells: possible implication of intracellular calcium. Cancer Lett 1995; 97:99-106.
29. Bernardi R, Jonson CS, Modzeleski RA et al. Antiproliferative effects of 1-alpha, 25-hydroxyvitamin D(3) and vitamin D analogs on timior-derived endothelial cells. Endocrinology 2002; 143:2508-14.
30. Cui R, Widlund HR, Feige E et al. Central Role of p53 in the suntan response and pathologic hyperpigmentation. Cell 2007; 128(5):853-864.